| Type 2 Diabetes Mellitus |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.98 |
| Heart Failure (HF) |
0 |
0.93 |
| Coronary Artery Disease (CAD) |
0 |
0.8 |
| Heart |
0 |
0.74 |
| Biomarker |
0 |
0.4 |
| Cardiovascular disease |
0 |
0.35 |
| Troponin |
0 |
0.99 |
| Deep Venous Thrombosis |
0 |
0.32 |
| Pulmonary Embolism |
0 |
0.32 |
| Colorado |
0 |
0.1 |
| Statins |
0 |
0.1 |
| Lipids Management |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| GLP-1 Receptor Agonist |
0 |
0.08 |
| B-Type Natriuretic Peptide |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.07 |
| Obesity |
0 |
0.07 |